About this trial
This study aims to evaluate the effectiveness of transcutaneous electrical nerve stimulation (TENS) for pain management during labor induction by cervical ripening.
Labor induction is a common obstetric procedure and cervical ripening may be associated with painful uterine contractions. Non-pharmacological analgesic methods such as TENS could help improve pain management during this phase. However, evidence regarding its effectiveness in this context remains limited.
This randomized, controlled, open-label monocentric study will compare the use of TENS in addition to usual analgesic care versus usual analgesic care alone in pregnant women undergoing labor induction with cervical ripening. The primary objective is to assess whether TENS reduces the need for neuraxial analgesia or delays its use during labor.
Eligibility criteria
Qualifiers
Pregnant women aged 18 years or older
Gestational age ≥ 37 weeks of amenorrhea
Indication for labor induction requiring cervical ripening
Planned cervical ripening using oral misoprostol (Angusta)
Disqualifiers
Contraindication to labor induction by cervical ripening
Contraindication to epidural analgesia
Major fetal anomaly
Maternal hypertension or hypotension
Trial design
Treatments tested in this trial
- Transcutaneous Electrical Nerve Stimulation (TENS)
- Standard analgesic care
Treatment groups
Locations
Sponsors and collaborators
HOT Noémie
Lead sponsor
Poissy-Saint Germain Hospital
Sponsor institution